RBC Europe’s Hologic HOLX Stock Holding History

RBC Europe’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000	Closed	-$73.8K	–	848
2021 Q3	$73.8K	Hold	1,000	–	–	﹤0.01%	486
2021 Q2	$66.7K	Hold	1,000	–	–	﹤0.01%	535
2021 Q1	$74.4K	Buy	+1,000	New	+$75.9K	﹤0.01%	462

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RBC Europe's HOLX Position: Q4 2021 in Review

RBC Europe sold out of Hologic (HOLX) in Q4 2021, closing a stake of 1,000 shares — an estimated $73.8K sold.

RBC Europe first reported a position in HOLX in Q1 2021 and held it in 3 quarters. The position peaked at $74.4K in Q1 2021. 679 funds tracked by Wall St. Rank hold HOLX as of Q4 2021.

RBC Europe reported no remaining Hologic position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 1,000 Hologic shares in Q4 2021, an estimated $73.8K.
RBC Europe first reported a position in Hologic in Q1 2021 and held it in 3 quarters.
RBC Europe's Hologic position peaked at $74.4K in Q1 2021.
679 funds tracked by Wall St. Rank held Hologic as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.